KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Net Cash Flow (2016 - 2026)

Staar Surgical (STAA) has disclosed Net Cash Flow for 17 consecutive years, with -$23.4 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Net Cash Flow fell 23.29% year-over-year to -$23.4 million, compared with a TTM value of $7.6 million through Jan 2026, up 120.0%, and an annual FY2026 reading of $7.6 million, up 120.0% over the prior year.
  • Net Cash Flow was -$23.4 million for Q1 2026 at Staar Surgical, down from $8.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $54.7 million in Q4 2023 and bottomed at -$72.7 million in Q3 2022.
  • Average Net Cash Flow over 5 years is -$2.9 million, with a median of -$1.4 million recorded in 2022.
  • The sharpest move saw Net Cash Flow tumbled 1311.94% in 2022, then soared 1105.38% in 2024.
  • Year by year, Net Cash Flow stood at -$43.5 million in 2022, then soared by 225.7% to $54.7 million in 2023, then plummeted by 134.64% to -$19.0 million in 2024, then skyrocketed by 147.11% to $8.9 million in 2025, then crashed by 361.71% to -$23.4 million in 2026.
  • Business Quant data shows Net Cash Flow for STAA at -$23.4 million in Q1 2026, $8.9 million in Q3 2025, and -$6.7 million in Q2 2025.